What Asclepes Research does

Asclepes Research is a privately held US Contract Research Organization (CRO) headquartered in Panorama City, California, that conducts Phase I through Phase IV clinical trials with a specialist focus on central nervous system (CNS) and psychiatry indications across adult, geriatric, and pediatric populations. The firm operates an eight-site network spanning Southern California (Panorama City, Long Beach under the ALLIANCE for Research brand, Torrance, and Carson via Del Amo Behavioral Health System) and Florida (Brooksville and two Spring Hill locations), delivered through a Managed Network Organization (MNO) model marketed as Asclepes Research Centers (ARC). Core trial infrastructure includes inpatient, partial hospital, and outpatient programs; a USP 797 compliant hospital pharmacy at the Panorama City flagship; on-campus MRI/CT imaging; and bio-marker modalities spanning PSG/EEG/qEEG, PET/fMRI/sMRI/fcMRI, PD/PK and CSF sampling, psych/motor rating scales, and cognitive testing. The company serves pharmaceutical sponsors and CROs as enterprise customers and supplements enrollment with a dedicated patient recruitment office (1-844-283-3649) and website-driven volunteer sign-up; notable hospital and network partners include Mission Community Hospital, Del Amo Behavioral Health System, and Access Healthcare Network. The firm also owns and operates an AAHRPP-accredited Independent Central IRB (IRB Company, Inc.), led by COO Anil Sharma MD, providing regulatory oversight and a potential ancillary revenue lever.

The business model is professional services: Asclepes earns study conduct fees from sponsors and CROs for protocol execution, site management, regulatory submission, quality assurance, IRB services, data management, and statistical analysis through affiliated entities, while paying compensation (reported on IRS Form 1099-Other Income at $600 or above) to participating volunteers. The go-to-market is sales-led through direct sponsor/CRO relationships and supplemented by event-driven participation in CNS Summit, AAIC, CTAD, ASCP, and AAHRPP seminars, with content marketing and a recruitment call center supporting the patient-volunteer pipeline. The value proposition centers on CNS domain specialization, an unusually complete imaging and bio-marker stack for a small CRO, an owned AAHRPP-accredited Central IRB, and a harmonized multi-site MNO platform that compresses sponsor onboarding across two US states. Pricing is not publicly disclosed; study-participant compensation rates vary by protocol and inconvenience level as determined by the principal investigator, and revenue mechanics between sponsor and CRO are governed by individual study contracts.

Asclepes was founded in 2015 and operates with 11–50 employees. The team is anchored by six board-certified psychiatrists and four board-certified internists with 50–75+ years of collective research experience, including UCLA-NIH trained pharmacology expertise and academic affiliations at USC and the University of South Florida. The company actively pursues additional AAHRPP accreditation for its Clinical Pharmacology Unit beyond its current IRB accreditation, signaling a quality-differentiation strategy. The firm has no disclosed funding rounds, no subsidiaries, and no M&A activity in the input data, suggesting organic, operating-cash-financed growth across an expanding but still small absolute footprint.

Name

Asclepes Research

Legal name

Asclepes Research

Website

https://asclepes.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

11–50 employees

Short description

Asclepes Research is a private US Contract Research Organization operating an eight-site Phase I-IV clinical trial network across California and Florida under the Asclepes Research Centers brand, specializing in CNS, psychiatry, and general medicine trials for pharmaceutical sponsors and CROs, with an owned AAHRPP-accredited Central IRB.

Ownership category

akta.pro rank

Product category

Clinical Research Services (CRO)

NAICS

Scientific Research and Development Services (5417), Medical Laboratories (621511)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071), Services-Testing Laboratories (8734)

akta.pro primary industry

Clinical Trial Site Operations & Study Coordination (HLAGACAE)

akta.pro secondary industries

Investigator & Site Training / GCP Support (HLAGACAF), Clinical Site Start-Up & Activation (Regulatory/Ethics/Contracts) (HLAGACAC), Regulatory Strategy & Global Submissions (IND/CTA/NDA/BLA/MAA) (HLAGAKAA)

Keywords

• Clinical trial services
• CNS clinical research
• Contract research organization
• Phase I-IV studies
• Clinical research site

Headquarters

HQ city

Panorama City

HQ country

United States

HQ region

North America

Offices8 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

1. Clinical Trial Services for Sponsors/CROs: Asclepes Research provides Phase I-IV clinical trial services to pharmaceutical companies and Contract Research Organizations (CROs). Revenue is generated through study conduct fees, regulatory services, site management, and ancillary services including IRB, protocol writing, data management, and statistical analysis through affiliated companies.
2. Participant Compensation: Study participants receive compensation for their time and participation, with amounts of $600 or more reported to the IRS via Form 1099-Other Income. This is a cost to the company rather than a revenue stream.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Core offering

Asclepes Research is a Contract Research Organization that conducts Phase I-IV clinical trials with a specialization in Central Nervous System (CNS) and psychiatry studies across adult, geriatric, and pediatric populations. It operates a network of wholly owned and affiliated research sites in California and Florida, supplemented by an AAHRPP-accredited independent central IRB, providing sponsors and CROs with comprehensive site management, protocol design, regulatory oversight, biomarker and neuroimaging capabilities, and patient recruitment.

Product overview

Asclepes Research operates as a specialized Phase I-IV Clinical Pharmacology Unit and Research Center offering a unified suite of clinical trial services. The company provides comprehensive CNS-focused research across inpatient and outpatient settings for adult, geriatric, and pediatric populations. The portfolio includes core clinical trial conduct services, specialized bio-marker and imaging capabilities, protocol design services, and network-wide site management. The Asclepes Research Centers (ARC) network comprises wholly owned, network managed, and affiliated research sites providing harmonized SOPs, GCP-trained staff, and quality assurance programs.

Differentiator

Problem solved

Functional benefit

Products and services

• Phase I-IV Clinical Trials End-to-end Phase I through Phase IV clinical trial conduct for pharmaceutical sponsors and CROs, including inpatient and outpatient settings, with primary specialization in Central Nervous System and psychiatry research across adult, geriatric, and pediatric populations. Delivered through the Asclepes Research Centers (ARC) network of wholly owned, network managed, and affiliated sites with harmonized SOPs and GCP-trained staff.
• Site Management Services Network-level site management services including centralized administration, contract and budget negotiations, regulatory document preparation and submission, standard study source documentation, subject recruitment with call center, recruiting database, and integrated website and social media platform. Sold to sponsors and CROs seeking multi-site operational support.
• Ancillary Clinical Research Services Supporting clinical research services delivered through affiliated companies, including IRB assistance, protocol writing and design, CSR report writing, monitoring, project management, statistical analysis, and data management. Sold to sponsors and CROs that need wraparound research operations support alongside site conduct.

Quantifiable outcome

• 50+ years of collective clinical research experience
• +2 more outcomes

Named customers2 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Three partnerships are on record, tiered core and minor.

• Del Amo Behavioral Health SystemcoreStrategic or Co-development PartnerDel Amo Behavioral Health System provides inpatient unit and partial hospital program facilities for Asclepes Research. Located at 23700 Camino Del Sol with partial hospital program at 16920 Avalon Blvd, Carson, CA 90746. The facility provides inpatient research capabilities and access to psychiatric patient populations.
• Mission Community HospitalcoreStrategic or Co-development PartnerMission Community Hospital provides inpatient unit at 18460 Roscoe Blvd and partial hospital program at 18450 Roscoe Blvd. Located in Panorama City, CA. Asclepes collaborates with the hospital for inpatient research facilities, emergency room access, and on-campus imaging capabilities including MRI/CT.
• Access Healthcare NetworkminorStrategic or Co-development PartnerCollaboration with Access Healthcare Network at Spring Hill, FL #1 location provides access to a database and referral network spanning over 200 clinics, enhancing patient recruitment capabilities.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Clinilabs: CNS-focused early-phase clinical research organization with Phase I unit and specialty expertise in psychiatry and neurology. Directly comparable in CNS specialization, investigator depth, and inpatient CRU capabilities.
• Elligo Health Research: Clinical research site network using a 'Research Ready' model to bring trials into community practices. Comparable multi-site SMO model, though Elligo emphasizes decentralized/community integration rather than CNS specialty.
• Worldwide Clinical Trials: Mid-size global CRO with a recognized specialty in CNS and psychiatry clinical trials across Phase I–IV. Closely comparable to Asclepes in CNS therapeutic focus, scientific depth, and study conduct model, though larger and globally distributed.
• Altasciences: Early-phase CRO with integrated clinical pharmacology units, bioanalytical labs, and CNS/neurology capabilities. Comparable to Asclepes in early-phase trial execution and inpatient research infrastructure.
• CTI Clinical Trial & Consulting Services: Mid-size CRO with strong neuroscience, rare disease, and specialty therapeutic capabilities. Comparable in operating model (multi-therapeutic CRO with clinical research unit) and competitive positioning against global mega-CROs.

Broad incumbents

• Syneos Health: Large biopharmaceutical solutions organization combining CRO services with commercial capabilities. Competes for CNS sponsor work, particularly late-phase, and serves as a likely sub-contracting counterparty for Asclepes.
• Parexel: Large global CRO with deep CNS and psychiatry therapeutic experience and integrated site/sponsor services. Overlaps with Asclepes on CNS Phase II–IV execution but at significantly larger scale and global reach.
• ICON plc: One of the largest global CROs with comprehensive clinical research, site, and laboratory services including CNS capabilities. Competes for large sponsor contracts but offers broader, less CNS-specialized services.
• Medpace: Mid-to-large global CRO with full-service Phase I–IV capabilities across multiple therapeutic areas including CNS. Competes with Asclepes for sponsor trial work but operates at materially larger scale with global footprint.

Emerging players

• Quotient Sciences: Clinical pharmacology and early-phase development CRO with translational sciences capabilities including CNS programs. Comparable to Asclepes in early-phase and proof-of-concept focus, though with stronger formulation/manufacturing integration.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/AsclepesRC
• Facebookfacebook.com/ASCLEPES
• LinkedInlinkedin.com/company/asclepes-research-centers-management-llc

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Asclepes Research